Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.

Cheever MA, Higano CS.

Clin Cancer Res. 2011 Jun 1;17(11):3520-6. doi: 10.1158/1078-0432.CCR-10-3126. Epub 2011 Apr 6.

PMID:
21471425
[PubMed - indexed for MEDLINE]
Free Article
2.

Comment on: A validated mathematical model of cell-mediated immune response to tumor growth.

Gowal S, de Giacomi M, Le Boudec JY.

Cancer Res. 2007 Sep 1;67(17):8419-21; author reply 8420-1. No abstract available.

PMID:
17804759
[PubMed - indexed for MEDLINE]
Free Article
3.

Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.

Yamaguchi S, Tatsumi T, Takehara T, Sakamori R, Uemura A, Mizushima T, Ohkawa K, Storkus WJ, Hayashi N.

Cancer. 2007 Oct 1;110(7):1469-77.

PMID:
17685394
[PubMed - indexed for MEDLINE]
Free Article
4.

Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.

Shinagawa N, Yamazaki K, Tamura Y, Imai A, Kikuchi E, Yokouchi H, Hommura F, Oizumi S, Nishimura M.

Cancer Immunol Immunother. 2008 Feb;57(2):165-74. Epub 2007 Jul 13.

PMID:
17628800
[PubMed - indexed for MEDLINE]
5.

Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells.

Preynat-Seauve O, Contassot E, Schuler P, French LE, Huard B.

Melanoma Res. 2007 Jun;17(3):169-76.

PMID:
17505262
[PubMed - indexed for MEDLINE]
6.

Larger numbers of immature dendritic cells augment an anti-tumor effect against established murine melanoma cells.

Lee TH, Cho YH, Lee MG.

Biotechnol Lett. 2007 Mar;29(3):351-7. Epub 2006 Dec 19.

PMID:
17180546
[PubMed - indexed for MEDLINE]
7.

Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model.

Cappuccio A, Elishmereni M, Agur Z.

Cancer Res. 2006 Jul 15;66(14):7293-300.

PMID:
16849579
[PubMed - indexed for MEDLINE]
Free Article
8.

Human T cell responses against melanoma.

Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P.

Annu Rev Immunol. 2006;24:175-208. Review.

PMID:
16551247
[PubMed - indexed for MEDLINE]
9.

Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations.

de Pillis LG, Gu W, Radunskaya AE.

J Theor Biol. 2006 Feb 21;238(4):841-62. Epub 2005 Sep 8.

PMID:
16153659
[PubMed - indexed for MEDLINE]
10.

A validated mathematical model of cell-mediated immune response to tumor growth.

de Pillis LG, Radunskaya AE, Wiseman CL.

Cancer Res. 2005 Sep 1;65(17):7950-8.

PMID:
16140967
[PubMed - indexed for MEDLINE]
Free Article
11.

Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results.

Trefzer U, Herberth G, Wohlan K, Milling A, Thiemann M, Sharav T, Sparbier K, Sterry W, Walden P.

Vaccine. 2005 Mar 18;23(17-18):2367-73.

PMID:
15755630
[PubMed - indexed for MEDLINE]
12.

Dendritic cell-based therapeutics for breast cancer.

Pilon-Thomas SA, Verhaegen ME, Mulé JJ.

Breast Dis. 2004;20:65-71. Review.

PMID:
15687708
[PubMed - indexed for MEDLINE]
13.

Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction.

Ludewig B, Krebs P, Junt T, Metters H, Ford NJ, Anderson RM, Bocharov G.

Eur J Immunol. 2004 Sep;34(9):2407-18.

PMID:
15307173
[PubMed - indexed for MEDLINE]
14.

Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy.

Chakraborty M, Abrams SI, Camphausen K, Liu K, Scott T, Coleman CN, Hodge JW.

J Immunol. 2003 Jun 15;170(12):6338-47.

PMID:
12794167
[PubMed - indexed for MEDLINE]
Free Article
15.

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.

Diefenbach A, Jensen ER, Jamieson AM, Raulet DH.

Nature. 2001 Sep 13;413(6852):165-71.

PMID:
11557981
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.

Fields RC, Shimizu K, Mulé JJ.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9482-7.

PMID:
9689106
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice.

DeMatos P, Abdel-Wahab Z, Vervaert C, Hester D, Seigler H.

J Surg Oncol. 1998 Jun;68(2):79-91. Review.

PMID:
9624036
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk